Skip to content

Prognostic factors in chronic rejection after human lungtransplantation

Prognostic factors in chronic rejection after human lungtransplantation - BOS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35319
Enrollment
110
Registered
2006-09-05
Start date
2007-01-02
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

genetische pathogenese bronchiolitis obliterans syndrome rejection

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who undergo a lung transplantation

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Prediction of BOS in patients after human lung transplantation in an early phase of the disease.

Secondary

MeasureTime frame
Reactivity of T cells against target antigens as detected by the SEREX techique. Relation of respiratory viruses and the development BOS. Relation of respiratory viruses and the development of BOS. Relation of genetic profile and the development of BOS. Relation of proteins in condensated breath in patients after human lung transplantation and the development of BOS.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)